Humacyte (HUMA) Financials

$0.60

$0.00 (0.31%)

As on 04-Sep-2026 13:37EDT

Market cap

$181 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

6.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	2.12	2.04	--	--	1.57	1.26
Cost of Revenue	16.26	17.05	7.19	76.55	8.26	61.34
Gross Profit	-14.14	-15.01	-7.19	-76.55	-6.69	-60.08
Operating Expenses	97.01	92.43	107.21	23.50	77.89	21.13
Operating Profit (EBIT)	-111.16	-107.44	-114.40	-100.05	-84.58	-81.21
Other Income	--	--	--	--	78.81	59.08
Profit before Tax	-96.74	-40.83	-148.70	-110.78	-11.97	-26.48
Provision for Tax	--	--	--	3.11	-76.18	-64.01
Profit after Tax (Net Income)	-96.74	-40.83	-148.70	-110.78	-11.97	-26.48
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-11.97	-26.48

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	31.26	3.11	-52.67	13.55	116.93	122.17
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	91.88	94.89	170.59	96.23	67.79	153.31
Current Liabilities	14.95	18.37	19.95	18.44	19.58	11.05
Total Liabilities	153.04	116.37	137.87	128.22	204.30	286.53

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	45.30	48.57	90.01	44.95	50.09	57.19
Current Assets	92.79	67.80	47.86	83.28	154.21	229.34
Total Assets	230.87	116.37	137.87	128.22	204.30	286.53
Total Debt*	66.18	64.85	16.54	57.45	50.07	51.18
Net Current Assets	--	49.42	27.91	64.84	134.63	218.29

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-105.04	-98.12	-73.31	-71.13	-81.19
Cash Flow from Investing Activities	--	-0.88	-1.57	-0.17	4.85	-8.22
Cash from Financing Activities	--	61.49	114.18	4.51	-1.45	266.98
Net Cash Inflow / Outflow	--	--	--	--	-67.73	177.57

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.51	-0.26	-1.26	-1.07	-0.12	-0.25
Cash EPS ($)	--	-0.21	-1.19	-0.99	-0.04	-0.17
Adjusted Book Value ($)	--	0.02	--	0.13	1.13	1.17
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.66	-0.83	-0.71	-0.69	-0.78
Free Cash Flow per Share ($)	--	-0.67	-0.84	-0.73	-0.70	-0.78

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-256.63	-852.96	-93.09	-7.03	-19.41
ROE (%)	-562.90	164.78	760.17	-169.81	-10.01	-27.46
ROA (%)	-49.51	-32.12	-111.77	-66.63	-4.88	-13.47
EBIT Margin (%)	-4,075.34	-1,451.57	--	--	-368.37	-1,752.10
Net Margin (%)	-4,560.82	-2,003.58	--	--	-14.89	-43.88
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-73.64	--	--	-1.00	0.24	-0.15
EBIT Growth (%)	-79.44	78.78	-33.83	-1,707.06	73.95	65.74
Net Profit Growth (%)	-64.91	72.54	-34.24	-825.83	54.81	60.20
EPS Growth (%)	-14.07	0.79	-0.17	-8.22	0.54	0.61
Book Value Growth (%)	412.08	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-3.72	-4.02	-2.66	-18.19	-28.68
Price / Book Value	6.18	48.86	-11.36	21.72	1.86	6.22
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	4.34	-7.48	-4.31	-2.81	47.39	-42.13
Close Price ($)	0.78	0.96	5.05	2.84	2.11	7.25
High Price ($)	2.84	5.48	9.97	5.60	8.04	17.45
Low Price ($)	0.55	0.91	2.48	1.96	1.96	7.08
Market Cap ($ Cr)	180.60	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	20.86	-0.31	4.24	0.43	0.42
Short term debt to equity ratio	0.05	0.78	-0.06	0.19	0.09	0.02
Current Ratio	6.21	3.69	2.40	4.52	7.88	20.75
Quick Ratio	5.74	2.95	2.40	--	7.88	20.75
Interest Coverage	-8.39	-2.63	-15.03	-15.79	-0.93	-5.09

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	15.56	21.64	--	--	1.98	13.94
Asset Turnover	0.01	0.02	--	--	0.01	0.01
Receivable days	--	39.52	--	--	24.16	41.79
Inventory Days	--	145.58	--	-0.15	-0.69	0.00
Payable days	--	105.99	278.89	19.29	81.61	13.00
Cash Conversion Cycle	--	79.10	--	--	-58.14	28.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.